These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 32650035)

  • 21. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic variability is an important risk factor for cardiovascular autonomic neuropathy in newly diagnosed type 2 diabetic patients.
    Xu W; Zhu Y; Yang X; Deng H; Yan J; Lin S; Yang H; Chen H; Weng J
    Int J Cardiol; 2016 Jul; 215():263-8. PubMed ID: 27128543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of continuous glucose monitoring for type 2 in diabetes management and research.
    Vigersky R; Shrivastav M
    J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A survey of glucose and lipid metabolism and concomitant diseases among inpatients in Guangdong province].
    Tang KX; Yu QQ; Liu LH; Xue YM; Yang HZ; Li L; Cai DH; Wu G; Zhang F; Zeng LY; Lin SD; Xiao ZH; Xia X; He XY; Xu F; Weng JP
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):196-200. PubMed ID: 19576085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.
    Tucholski K; Deja G; Skała-Zamorowska E; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):29-33. PubMed ID: 19454186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response between frequency of interruption of sedentary time and fasting glucose, the dawn phenomenon and night-time glucose in Type 2 diabetes.
    Paing AC; McMillan KA; Kirk AF; Collier A; Hewitt A; Chastin SFM
    Diabet Med; 2019 Mar; 36(3):376-382. PubMed ID: 30264906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.
    Kohnert KD; Vogt L; Augstein P; Heinke P; Zander E; Peterson K; Freyse EJ; Salzsieder E
    Horm Metab Res; 2009 Feb; 41(2):137-41. PubMed ID: 19214924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.
    Acciaroli G; Sparacino G; Hakaste L; Facchinetti A; Di Nunzio GM; Palombit A; Tuomi T; Gabriel R; Aranda J; Vega S; Cobelli C
    J Diabetes Sci Technol; 2018 Jan; 12(1):105-113. PubMed ID: 28569077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome Prediction in Acute Stroke Patients by Continuous Glucose Monitoring.
    Wada S; Yoshimura S; Inoue M; Matsuki T; Arihiro S; Koga M; Kitazono T; Makino H; Hosoda K; Ihara M; Toyoda K
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of Glycemic Control and Variability After Kidney Transplant.
    Aouad LJ; Clayton P; Wyburn KR; Gracey DM; Chadban SJ
    Transplantation; 2018 Sep; 102(9):1563-1568. PubMed ID: 29494418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of dusk phenomenon on total glucose exposure in Chinese people with type 2 diabetes.
    Huang Y; Xu Y; Qiu J; Jiang C; Tan W; Tao X; Gu Q; Sun J
    Medicine (Baltimore); 2021 Apr; 100(13):e25298. PubMed ID: 33787619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections.
    Volčanšek Š; Lunder M; Janež A
    Diabetes Technol Ther; 2019 Oct; 21(10):566-574. PubMed ID: 31335199
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
    Ohara M; Hiromura M; Nagaike H; Kohata Y; Fujikawa T; Goto S; Sato N; Kushima H; Terasaki M; Yamamoto T; Mori Y; Hayashi T; Fukui T; Yamagishi SI; Hirano T
    Diabetes Res Clin Pract; 2019 Dec; 158():107904. PubMed ID: 31672500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of time point of calibration on accuracy of continuous glucose monitoring in individuals with type 1 diabetes.
    Zueger T; Diem P; Mougiakakou S; Stettler C
    Diabetes Technol Ther; 2012 Jul; 14(7):583-8. PubMed ID: 22512266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study.
    Xu SY; KeLi ; Zhang Z; Liu CY; Guo QY; Lu B; Gu P; Shao JQ
    Diabetes Res Clin Pract; 2021 Mar; 173():108684. PubMed ID: 33539867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
    Jendle J; Testa MA; Martin S; Jiang H; Milicevic Z
    Diabetes Obes Metab; 2016 Oct; 18(10):999-1005. PubMed ID: 27279266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.